USA Capacity Utilization Rate for Jun 80.000% vs 80.600% consensus estimate. The prior reading was 80.300%.
FDA Clears Akouos’ Gene Therapy Trial For Genetic Form Of Hearing Loss
The FDA has signed off Akouos Inc’s (NASDAQ:AKUS) Investigational New Drug application to initiate a Phase 1/2 trial of AK-OTOF, gene…
